144 related articles for article (PubMed ID: 15998655)
1. Online measurement of haemoglobin concentration.
Chesterton L; Lambie SH; Hulme LJ; Taal M; Fluck RJ; McIntyre CW
Nephrol Dial Transplant; 2005 Sep; 20(9):1951-5. PubMed ID: 15998655
[TBL] [Abstract][Full Text] [Related]
2. Influence of the ionic dialysance monitor on Kt measurement in hemodialysis.
Maduell F; Vera M; Arias M; Serra N; Blasco M; Bergadá E; Fontsere N; Cases A; Campistol JM
Am J Kidney Dis; 2008 Jul; 52(1):85-92. PubMed ID: 18455852
[TBL] [Abstract][Full Text] [Related]
3. Haemodialysis with on-line monitoring equipment: tools or toys?
Locatelli F; Buoncristiani U; Canaud B; Köhler H; Petitclerc T; Zucchelli P
Nephrol Dial Transplant; 2005 Jan; 20(1):22-33. PubMed ID: 15632348
[TBL] [Abstract][Full Text] [Related]
4. Prediction of time-averaged concentration of haemoglobin in haemodialysis patients.
Krisper P; Quehenberger F; Schneditz D; Holzer H; Polaschegg HD
Nephrol Dial Transplant; 2003 Oct; 18(10):2082-7. PubMed ID: 13679484
[TBL] [Abstract][Full Text] [Related]
5. Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels.
Roberts TL; Foley RN; Weinhandl ED; Gilbertson DT; Collins AJ
Nephrol Dial Transplant; 2006 Jun; 21(6):1652-62. PubMed ID: 16449283
[TBL] [Abstract][Full Text] [Related]
6. Correlates of habitual physical activity in chronic haemodialysis patients.
Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
[TBL] [Abstract][Full Text] [Related]
7. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
[TBL] [Abstract][Full Text] [Related]
8. Continuous online monitoring of ionic dialysance allows modification of delivered hemodialysis treatment time.
Chesterton LJ; Priestman WS; Lambie SH; Fielding CA; Taal MW; Fluck RJ; McIntyre CW
Hemodial Int; 2006 Oct; 10(4):346-50. PubMed ID: 17014509
[TBL] [Abstract][Full Text] [Related]
9. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
Flisiński M; Strózecki P; Stefańska A; Zarzycka-Lindner G; Brymora A; Manitius J
Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
[TBL] [Abstract][Full Text] [Related]
10. Relative blood volume measurements during hemodialysis: comparisons between three noninvasive devices.
Dasselaar JJ; Huisman RM; DE Jong PE; Franssen CF
Hemodial Int; 2007 Oct; 11(4):448-55. PubMed ID: 17922743
[TBL] [Abstract][Full Text] [Related]
11. Use of 12x/month haemoglobin monitoring with a computer algorithm reduces haemoglobin variability.
Ho WR; Germain MJ; Garb J; Picard S; Mackie MK; Bartlett C; Will EJ
Nephrol Dial Transplant; 2010 Aug; 25(8):2710-4. PubMed ID: 20176613
[TBL] [Abstract][Full Text] [Related]
12. Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance.
Uhlin F; Fridolin I; Magnusson M; Lindberg LG
Nephrol Dial Transplant; 2006 Aug; 21(8):2225-31. PubMed ID: 16611681
[TBL] [Abstract][Full Text] [Related]
13. Utility of point-of-care haemoglobin measurement in the HemoCue-B haemoglobin for the initial diagnosis of anaemia.
Muñoz M; Romero A; Gómez JF; Manteca A; Naveira E; Ramírez G
Clin Lab Haematol; 2005 Apr; 27(2):99-104. PubMed ID: 15784124
[TBL] [Abstract][Full Text] [Related]
14. Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran.
Mahdavi-Mazdeh M; Zamyadi M; Nafar M
Nephrol Dial Transplant; 2008 Jan; 23(1):288-93. PubMed ID: 17965435
[TBL] [Abstract][Full Text] [Related]
15. Clinical use of continuous blood volume monitoring.
Lopot F
EDTNA ERCA J; 1996; 22(4):7-11. PubMed ID: 10723339
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients.
Kim JM; Ihm CH; Kim HJ
Int J Lab Hematol; 2008 Feb; 30(1):46-52. PubMed ID: 18190467
[TBL] [Abstract][Full Text] [Related]
17. Is early treatment of anaemia with epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial.
Macdougall IC; Temple RM; Kwan JT
Nephrol Dial Transplant; 2007 Mar; 22(3):784-93. PubMed ID: 16968726
[TBL] [Abstract][Full Text] [Related]
18. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
[TBL] [Abstract][Full Text] [Related]
19. Hemodialysis blood access flow rates can be estimated accurately from on-line dialysate urea measurements and the knowledge of effective dialyzer urea clearance.
Lindsay RM; Sternby J; Olde B; Persson R; Thatcher ME; Sargent K
Clin J Am Soc Nephrol; 2006 Sep; 1(5):960-4. PubMed ID: 17699313
[TBL] [Abstract][Full Text] [Related]
20. Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study.
de Francisco AL; Sulowicz W; Klinger M; Niemczyk S; Vargemezis V; Metivier F; Dougherty FC; Oguey D;
Int J Clin Pract; 2006 Dec; 60(12):1687-96. PubMed ID: 17109676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
